Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?
Balázs Németh,1,2 Iván Péter,1 Imre Boncz,1 Anna Jagicza,1 István Kiss,2 Ágnes Csergő,2 Tamás Kőszegi,3,4 Péter Kustán,3,4 Iván G Horváth,5 Zénó Ajtay1,51Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary; 2Department of Public Health Medicine, Medical School, University of Pécs, Pécs...
Saved in:
Main Authors: | Németh B (Author), Péter I (Author), Boncz I (Author), Jagicza A (Author), Kiss I (Author), Csergő Á (Author), Kőszegi T (Author), Kustán P (Author), Horváth IG (Author), Ajtay Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke
by: Kai Jing, et al.
Published: (2024) -
Orosomucoid: a promising biomarker for the assessment of exercise-induced fatigue triggered by basic combat training
by: Yi Ruan, et al.
Published: (2022) -
Commentary on "Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke"
by: Raja Kannan
Published: (2024) -
Cardiovascular involvement in psoriatic arthritis
by: V. De Gennaro Colonna, et al.
Published: (2011) -
IMAGING OF PSORIATIC ARTHRITIS
by: S. D'Angelo, et al.
Published: (2011)